Grantclosed🌐 United StatesPAR-25-028

Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)

National Institutes of Health

Details?

Posted: Dec 11, 2024
Response deadline: Jan 11, 2026, 12:00 AM UTC
Type: Grant
Category: 93.838, 93.233, 93.839, 93.840, 93.837
Status: closed
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: PAR-25-028

Doc Type: synopsis
Opp Status: archived

Similar past solicitations

Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
United States · Dec 11, 2024
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
United States · Feb 2, 2024
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
United States · Jul 12, 2022
Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Clinical Trials (UH3 Clinical Trial Optional)
United States · Jun 17, 2025
Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiated Studies (U01 Clinical Trial Not Allowed)
United States · Jun 17, 2025
NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)
United States · Nov 6, 2024

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.